Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 03, 2022	Jul. 04, 2021	Jul. 03, 2022	Jul. 04, 2021
Operating activities:
Net income	$ 179,212	$ 245,930	$ 356,174	$ 625,235
Loss from discontinued operations and dispositions, net of income taxes	40	38	81	76
Income from continuing operations	179,252	245,968	356,255	625,311
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and other costs, net	11,928	5,063	25,312	10,807
Depreciation and amortization			239,457	145,822
Stock-based compensation			31,292	12,361
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability			1,363	477
Amortization of deferred debt financing costs and accretion of discounts and debt extinguishment costs			4,340	1,724
Change in fair value of financial securities	(2,910)	(8,633)	9,215	(27,931)
Amortization of acquired inventory revaluation			33,724	5,303
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net			47,485	155,270
Inventories			(70,297)	7,239
Accounts payable			(7,382)	(26,795)
Increase (Decrease) in Accrued Expenses and Other			(290,064)	(148,226)
Net cash provided by operating activities			380,700	761,362
Investing activities:
Capital expenditures			(52,585)	(34,675)
Payments to Acquire Investments			(27,245)	(14,507)
Proceeds from Divestiture of Businesses			1,054	0
Cash paid for acquisitions, net of cash acquired			(5,885)	(702,697)
Net cash used in investing activities			(84,661)	(751,879)
Financing activities:
Payments of borrowings			220,000	763,545
Proceeds from borrowings			220,000	729,000
Repayments of Term Loan			(450,000)	0
Repayments of Senior Debt			0	(339,605)
Proceeds from sale of senior debt			0	799,856
Payments of debt financing and equity issuance costs			0	(8,242)
Settlement of cash flow hedges			(762)	(5,935)
Net payments on other credit facilities			(830)	(11,826)
Proceeds from issuance of common stock under stock plans			5,841	14,185
Purchases of common stock			(56,048)	(72,924)
Dividends paid			(17,667)	(15,697)
Net cash provided by (used in) financing activities			(519,466)	325,267
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents			(33,977)	(10,659)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent			(257,404)	324,091
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period			619,337	402,613
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period	361,933	726,704	361,933	726,704
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	360,860	572,810	360,860	572,810
Restricted Cash, Current	1,073	1,750	1,073	1,750
Restricted Cash, Noncurrent	0	152,144	0	152,144
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 361,933	$ 726,704	$ 361,933	$ 726,704